Inhibitors of CCR9 activity

Details for Australian Patent Application No. 2006328901 (hide)

Owner Novartis AG

Inventors Winiski, Anthony; Werner, Gudrun; Carballido Herrera, Jose M.; Lehr, Philipp; Jaksche, Herbert

Agent Davies Collison Cave

Pub. Number AU-A-2006328901

PCT Pub. Number WO2007/071441

Priority 0526445.2 23.12.05 GB

Filing date 22 December 2006

Wipo publication date 28 June 2007

International Classifications

C07D 333/34 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

A61K 31/381 (2006.01) - having five-membered rings

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C07C 311/14 (2006.01) Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups

Event Publications

3 July 2008 PCT application entered the National Phase

  PCT publication WO2007/071441 Priority application(s): WO2007/071441

19 July 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006328902-Inhibitors of CCR9 activity

2006328900-Inhibitors of CCR9 activity